Login / Signup

Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells.

Krista KinneerMatt FlynnSuneetha B ThomasJohn MeekinReena VarkeyXiaodong XiaoHaihong ZhongShannon BreenPaul G HynesRyan FlemingBinyam BezabehCui Tracy ChenLeslie WetzelRuoyan ChenNazzareno DimasiYu-Tzu TaiKenneth C AndersonRonald HerbstPhilip W HowardElaine M HurtDavid A Tice
Published in: Leukemia (2018)
Keyphrases
  • multiple myeloma
  • cancer therapy
  • drug delivery
  • bone marrow
  • clinical evaluation